Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex

Journal of Virology

Volumn 88, Issue 17, 2014, Pages 9830-9841

  Lei, Xiaobo ^a   Han, Ning ^a   Xiao, Xia ^a   Jin, Qi ^a   He, Bin ^b   Wang, Jianwei ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3C PROTEASES; CYSTEINE PROTEINASE; CYTOKINE; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MUTANT PROTEIN; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TAB1 PROTEIN, HUMAN; TAB2 PROTEIN, HUMAN; TAB3 PROTEIN, HUMAN; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANTAGONISTS AND INHIBITORS; CELL LINE; ENTEROVIRUS A; GENETICS; HUMAN; HYDROLYSIS; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SUBSTITUTION; CELL LINE; CYSTEINE ENDOPEPTIDASES; CYTOKINES; ENTEROVIRUS A, HUMAN; HUMANS; HYDROLYSIS; IMMUNE EVASION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE KINASE KINASES; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; VIRAL PROTEINS;

EID: 84921981380     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01425-14     Document Type: Article

References (40)

1. McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26:91-107. http://dx.doi.org/10.1111/j.1574-6976.2002.tb00601.x.
2. Li ML, Hsu TA, Chen TC, Chang SC, Lee JC, Chen CC, Stollar V, Shih SR. 2002. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 293:386-395. http://dx.doi.org/10.1006/viro.2001.1310.
3. Shih SR, Chiang C, Chen T, Wu CN, Hsu J, Lee J, Hwang MJ, Li M, Chen G, Ho MS. 2004. Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. J. Biomed. Sci. 11:239-248. http://dx.doi.org/10.1007/BF02256567.
4. Sim AC, Luhur A, Tan TM, Chow VT, Poh CL. 2005. RNA interference against enterovirus 71 infection. Virology 341:72-79. http://dx.doi.org/10.1016/j.virol.2005.06.047.
5. Hung HC, Wang HC, Shih SR, Teng IF, Tseng CP, Hsu JT. 2011. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J. Infect. Dis. 203:1784-1790. http://dx.doi.org/10.1093/infdis/jir174.
6. Lei X, Sun Z, Liu X, Jin Q, He B, Wang J. 2011. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 85:8811-8818. http://dx.doi.org/10.1128/JVI.00447-11.
7. Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J. 2013. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J. Virol. 87:1690-1698. http://dx.doi.org/10.1128/JVI.01855-12.
8. Lei X, Liu X, Ma Y, Sun Z, Yang Y, Jin Q, He B, Wang J. 2010. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation. J. Virol. 84:8051-8061. http://dx.doi.org/10.1128/JVI.02491-09.
9. Dai L, Aye Thu C, Liu X, Xi J, Cheung PC. 2012. TAK1, more than just innate immunity. IUBMB Life 64:825-834. http://dx.doi.org/10.1002/iub.1078.
10. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. 1995. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270:2008-2011. http://dx.doi.org/10.1126/science.270.5244.2008.
11. Ono K, Ohtomo T, Sato S, Sugamata Y, Suzuki M, Hisamoto N, Ninomiya-Tsuji J, Tsuchiya M, Matsumoto K. 2001. An evolutionarily conserved motif in the TAB1 C-terminal region is necessary for interaction with and activation of TAK1 MAPKKK. J. Biol. Chem. 276:24396-24400. http://dx.doi.org/10.1074/jbc.M102631200.
12. Besse A, Lamothe B, Campos AD, Webster WK, Maddineni U, Lin SC, Wu H, Darnay BG. 2007. TAK1-dependent signaling requires functional interaction with TAB2/TAB3. J. Biol. Chem. 282:3918-3928. http://dx.doi.org/10.1074/jbc.M608867200.
13. Cheung PC, Nebreda AR, Cohen P. 2004. TAB3, a new binding partner of the protein kinase TAK1. Biochem. J. 378:27-34. http://dx.doi.org/10.1042/BJ20031794.
14. Ishitani T, Takaesu G, Ninomiya-Tsuji J, Shibuya H, Gaynor RB, Matsumoto K. 2003. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J. 22:6277-6288. http://dx.doi.org/10.1093/emboj/cdg605.
15. Omori E, Matsumoto K, Sanjo H, Sato S, Akira S, Smart RC, Ninomiya-Tsuji J. 2006. TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. J. Biol. Chem. 281:19610-19617. http://dx.doi.org/10.1074/jbc.M603384200.
16. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O, Akira S. 2005. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6:1087-1095. http://dx.doi.org/10.1038/ni1255.
17. Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, Hayden MS, Lee KY, Bussey C, Steckel M, Tanaka N, Yamada G, Akira S, Matsumoto K, Ghosh S. 2005. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19:2668-2681. http://dx.doi.org/10.1101/gad.1360605.
18. Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, Irie K, Ninomiya-Tsuji J, Matsumoto K. 2000. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell 5:649-658. http://dx.doi.org/10.1016/S1097-2765(00)80244-0.
19. Blonska M, Shambharkar PB, Kobayashi M, Zhang D, Sakurai H, Su B, Lin X. 2005. TAK1 is recruited to the tumor necrosis factor-alpha (TNFalpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-κB activation. J. Biol. Chem. 280:43056-43063. http://dx.doi.org/10.1074/jbc.M507807200.
20. Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM, Aggarwal BB. 2007. Evidence that TNFTNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 26:1385-1397. http://dx.doi.org/10.1038/sj.onc.1209945.
21. Kanayama A, Seth RB, Sun L, Ea CK, Hong M, Shaito A, Chiu YH, Deng L, Chen ZJ. 2004. TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell 15:535-548. http://dx.doi.org/10.1016/j.molcel.2004.08.008.
22. Feng Z, Cerveny M, Yan Z, Hem B. 2007. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA dependent protein kinase PKR. J. Virol. 81:182-192. http://dx.doi.org/10.1128/JVI.01006-06.
23. Weng KF, Li ML, Huang CT, Shih SR. 2009. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 5:e1000593. http://dx.doi.org/10.1371/journal.ppat.1000593.
24. Yalamanchili P, Datta U, Dasgupta A. 1997. Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus-encoded protease 3Cpro. J. Virol. 71:1220-1226.
25. Joachims M, Van Breugel PC, Lloyd RE. 1999. Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J. Virol. 73:718-727.
26. Kuyumcu-Martinez NM, Van Eden ME, Younan P, Lloyd RE. 2004. Cleavage of poly(A)-binding protein by poliovirus 3C protease inhibits host cell translation: a novel mechanism for host translation shutoff. Mol. Cell. Biol. 24:1779-1790. http://dx.doi.org/10.1128/MCB.24.4.1779-1790.2004.
27. Kundu P, Raychaudhuri S, Tsai W, Dasgupta A. 2005. Shutoff of RNA polymerase II transcription by poliovirus involves 3C protease-mediated cleavage of the TATA-binding protein at an alternative site: incomplete shutoff of transcription interferes with efficient viral replication. J. Virol. 79:9702-9713. http://dx.doi.org/10.1128/JVI.79.15.9702-9713.2005.
28. Cui S, Wang J, Fan T, Qin B, Guo L, Lei X, Wang M, Jin Q. 2011. Crystal structure of human enterovirus 71 3C protease. J. Mol. Biol. 408: 449-461. http://dx.doi.org/10.1016/j.jmb.2011.03.007.
29. Wang J, Fan T, Yao X, Wu Z, Guo L, Lei X, Wang M, Jin Q, Cui S. 2011. Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues. J. Virol. 85:10021-10030. http://dx.doi.org/10.1128/JVI.05107-11.
30. Chang L, Huang L, Gau S, Wu Y, Hsia S, Fan T, Lin K, Huang Y, Lu C, Lin T. 2007. Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med. 356:1226-1234. http://dx.doi.org/10.1056/NEJMoa065954.
31. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. 1999. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 341:929-935. http://dx.doi.org/10.1056/NEJM199909233411301.
32. Huang C, Liu C, Chang YC, Chen C, Wang S, Yeh TF. 1999. Neurologic complications in children with enterovirus 71 infection. N. Engl. J. Med. 341:936-942. http://dx.doi.org/10.1056/NEJM199909233411302.
33. Liu ML, Lee YP, Wang YF, Lei HY, Liu CC, Wang SM, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2005. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 86:3263-3269. http://dx.doi.org/10.1099/vir.0.81195-0.
34. Wang B, Xi X, Lei X, Zhang X, Cui S, Wang J, Jin Q, Zhao Z. 2013. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog. 9:e1003231. http://dx.doi.org/10.1371/journal.ppat.1003231.
35. Zheng Z, Li H, Zhang Z, Meng J, Mao D, Bai B, Lu B, Mao P, Hu Q, Wang H. 2011. Enterovirus 71 2C protein inhibits TNF-alpha-mediated activation of NF-kappaB by suppressing IκB kinase beta phosphorylation. J. Immunol. 187:2202-2212. http://dx.doi.org/10.4049/jimmunol.1100285.
36. Lu J, Yi L, Zhao J, Yu J, Chen Y, Lin MC, Kung HF, He ML. 2012. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 86:3767-3776. http://dx.doi.org/10.1128/JVI.06687-11.
37. Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, Barker N, Waterman M, Bowerman B, Clevers H, Shibuya H, Matsumoto K. 1999. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 399:798-802. http://dx.doi.org/10.1038/21674.
38. White JP, Cardenas AM, Marissen WE, Lloyd RE. 2007. Inhibition of cytoplasmic mRNA stress granule formation by a viral proteinase. Cell Host Microbe 2:295-305. http://dx.doi.org/10.1016/j.chom.2007.08.006.
39. Ng CS, Jogi M, Yoo JS, Onomoto K, Koike S, Iwasaki T, Yoneyama M, Kato H, Fujita T. 2013. Encephalomyocarditis virus disrupts stress granules, the critical platform for triggering antiviral innate immune responses. J. Virol. 87:9511-9522. http://dx.doi.org/10.1128/JVI.03248-12.
40. Doukas T, Sarnow P. 2011. Escape from transcriptional shutoff during poliovirus infection: NF-κB-responsive genes IκBa and A20. J. Virol. 85: 10101-10108. http://dx.doi.org/10.1128/JVI.00575-11.